Mark A. Rizzacasa

Mark A. Rizzacasa

Auto-generated profile, based on publicly available information

Mark A. Rizzacasa

School of Chemistry, The Bio21 Institute, The University of Melbourne, Melbourne, Victoria 3010, Australia

Research Focus & Metrics

Academic Career Length

40Years (1987-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Cell Reports
Verified
Journal Article
Open access
JVJames E. Vince
James E. Vince
Dominic De NardoDominic De Nardo
Dominic De Nardo
WGWenqing Gao
Wenqing Gao
AVAngelina J. Vince
Angelina J. Vince
CHCathrine Hall
Cathrine Hall
KLKate E. Lawlor
Kate E. Lawlor
Intrinsic apoptosis resulting from BAX/BAK-mediated mitochondrial membrane damage is regarded as immunologically silent. We show here that in macrophages, BAX/BAK activation results in inhibitor of apoptosis (IAP) protein degradation to promote caspase-8-mediated activation of IL-1β. Furthermore, BAX/BAK signaling induces a parallel pathway to NLRP3 inflammasome-mediated caspase-1-dependent IL-1β maturation that requires potassium efflux. Remarkably, following BAX/BAK activation, the apoptotic executioner caspases, caspase-3 and -7, act upstream of both caspase-8 and NLRP3-induced IL-1β maturation and secretion. Conversely, the pyroptotic cell death effectors gasdermin D and gasdermin E are not essential for BAX/BAK-induced IL-1β release. These findings highlight that innate immune cells undergoing BAX/BAK-mediated apoptosis have the capacity to generate pro-inflammatory signals and provide an explanation as to why IL-1β activation is often associated with cellular stress, such as during chemotherapy.

29 December 2004 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
TMThomas Munro
Thomas Munro
MRMark A. Rizzacasa
Mark A. Rizzacasa
BRBryan L. Roth
Bryan L. Roth
BTBeth A. Toth
Beth A. Toth
FYFeng Yan
Feng Yan

13 January 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
TATim E. Adams
Tim E. Adams
MSMariana El Sous
Mariana El Sous
BHBill Hawkins
Bill Hawkins
SHSebastian Hirner
Sebastian Hirner
GHGeorgina Holloway
Georgina Holloway
MRMark A. Rizzacasa
Mark A. Rizzacasa


4 October 2007 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
MSMariana El Sous
Mariana El Sous
MKMui Ling Khoo
Mui Ling Khoo
GHGeorgina Holloway
Georgina Holloway
DODavid Owen
David Owen
PSPeter J. Scammells
Peter J. Scammells
MRMark A. Rizzacasa
Mark A. Rizzacasa

11 October 2012 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
LLL M Lindqvist
L M Lindqvist
IVI Vikström
I Vikström
JCJ M Chambers
J M Chambers
KMK McArthur
K McArthur
MAMary Ann Anderson
Mary Ann Anderson
DHDc S Huang
Dc S Huang
There is significant interest in treating cancers by blocking protein synthesis, to which hematological malignancies seem particularly sensitive. The translation elongation inhibitor homoharringtonine (Omacetaxine mepesuccinate) is undergoing clinical trials for chronic myeloid leukemia, whereas the translation initiation inhibitor silvestrol has shown promise in mouse models of cancer. Precisely how these compounds induce cell death is unclear, but reduction in Mcl-1, a labile pro-survival Bcl-2 family member, has been proposed to constitute the critical event. Moreover, the contribution of translation inhibitors to neutropenia and lymphopenia has not been precisely defined. Herein, we demonstrate that primary B cells and neutrophils are highly sensitive to translation inhibitors, which trigger the Bax/Bak-mediated apoptotic pathway. However, contrary to expectations, reduction of Mcl-1 did not significantly enhance cytotoxicity of these compounds, suggesting that it does not have a principal role and cautions that strong correlations do not always signify causality. On the other hand, the killing of T lymphocytes was less dependent on Bax and Bak, indicating that translation inhibitors can also induce cell death via alternative mechanisms. Indeed, loss of clonogenic survival proved to be independent of the Bax/Bak-mediated apoptosis altogether. Our findings warn of potential toxicity as these translation inhibitors are cytotoxic to many differentiated non-cycling cells.